🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Registry of Patients With chrOnic thromboemboLic Pulmonary hypErTension

Recruitingn/aAges 18 Years - anyAllIrina E. Chazova
NCT07254078 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this observational study is to gather information on background, medical history, symptoms and physical condition, treatment options of people with chronic thromboembolic pulmonary hypertension in real clinical practice in Russia. The main question it aims to answer is: Which factors most influence the prognosis of participants?

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Presence of a confirmed diagnosis of CTEPH Exclusion Criteria: * Presence of pulmonary hypertension of a different etiology than CTEPH
💊

What it tests

  • Pulmonary endarterectomy
  • Balloon pulmonary angioplasty
  • Pulmonary hypertension-specific therapy
📍

Where

1 site
National Medical Research Center of Cardiology after academician E.I. Chazov
Moscow, Russia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy